More from Dividend.com
Referenced Stocks

MKM Upgrades Merck to a “Buy” (MRK)

By Dividend.com November 20, 2012, 09:31:25 AM EDT

MKM reported on Tuesday that they have upgraded healthcare company, Merck & Co., Inc.( MRK ) to a "Buy".

The firm reported that they have upgraded MRK from "Neutral" to a "Buy," and have given the company a price target of $51. This price target suggests a 15% increase over the stock's current price of $43.38.

Merck & Co. shares were mostly flat during premarket trading Tuesday. The stock is up 14.96% YTD.

The Bottom Line
Shares of Merck ( MRK ) have a 3.81% dividend yield, based on last night's closing stock price of $43.34. The stock has technical support in the $41-$42 price area. If the shares can firm up, we see overhead resistance around the $46-$48 price levels.

Merck & Co., Inc.( MRK ) is not recommended at this time, holding a Dividend.com DARS™ Rating of 3.4 out of 5 stars.

Be sure to visit our complete recommended list of the Best Dividend Stocks , as well as a detailed explanation of our ratings system here .




The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.


This article appears in: Investing, Stocks

Referenced Stocks: MRK



Latest News Video



From Our Trusted News Source





Most Active by Volume:

Company Last Sale Change Net / %
BAC $ 13.43 0.07  0.52%
CSCO $ 24.24 0.35  1.48%
MSFT $ 34.87 0.79  2.32%
F $ 15.08 0.44  3.01%
ARUN $ 13.10 4.51  25.61%
SIRI $ 3.50 0.05  1.45%
GE $ 23.46 0.19  0.82%
S $ 7.32 0.04  0.55%